title: The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial.
authors.affiliation: Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. kampman@research.trc.upenn.edu
authors.forename: K M
authors.initials: KM
authors.lastname: Kampman
authors.forename: M
authors.initials: M
authors.lastname: Rukstalis
authors.forename: H
authors.initials: H
authors.lastname: Pettinati
authors.forename: E
authors.initials: E
authors.lastname: Muller
authors.forename: T
authors.initials: T
authors.lastname: Acosta
authors.forename: P
authors.initials: P
authors.lastname: Gariti
authors.forename: R
authors.initials: R
authors.lastname: Ehrman
authors.forename: C P
authors.initials: CP
authors.lastname: O'Brien
mesh_terms: D000328:Adult; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003042:Cocaine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D005277:Fenfluramine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000009:adverse effects*; D010645:Phentermine / Q000627:therapeutic use*; D010865:Pilot Projects; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000697:Central Nervous System Stimulants; D003042:Cocaine; D005277:Fenfluramine; D009294:Narcotics; D010645:Phentermine; D017367:Selective Serotonin Reuptake Inhibitors